Further studies to determine whether IP-10 levels in NLF or serum can serve as biomarkers for the onset and resolution of CF APE, or other disorders dominated by P. aeruginosa or other chronic infections are warranted. The gene discussed is CXCL10; the disease is apparent mineralocorticoid excess.